Afuco™ Anti-IL17RA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-217) (CAT#: AFC-TAB-217)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL17RA. It is a humanized monoclonal antibody used in the treatment of autoimmune diseases.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • ELISA, FC, IP, FuncS, IF
  • Conjugate
  • Unconjugated
  • Generic Name
  • Ixekizumab
  • Related Disease
  • Psoriasis

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IL17RA; interleukin 17 receptor A; IL17R, interleukin 17 receptor; interleukin-17 receptor A; CD217; CDw217; hIL 17R; IL 17RA; IL-17 receptor A; IL17R; CANDF5; IL-17RA; hIL-17R; FLJ32274; FLJ36453; MGC10262;

Related Resources

  • Biosimilar Overview
Please refer to Ixekizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ixekizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Ixekizumab"

DrugMonitor™ Anti-Ixekizumab Antibody (VS-1224-YC622)
Ixekizumab is a humanized IgG4 monoclonal antibody against interleukin-17A (IL-17A), preventing interaction with IL-17A receptors, approved for treating moderate-to-severe plaque psoriasis in adults. The DrugMonitor™ Anti-Ixekizumab Antibody (VS-1224-YC622) is an anti-drug antibody (ADA) against Ixekizumab. This drug-based antibody is raised in mice immunized with the Ixekizumab. The anti-Ixekizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Ixekizumab in samples.

See other products for "IL17RA"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Single Domain Antibody Products Human Antibody Products Humanized Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products ADCC Enhanced Antibody Products ScFv Antibody Products Fab Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-217. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare